Result of interim analysis of overall survival in the GCIG ICON7 phase III randomized trial of bevacizumab in women with newly diagnosed ovarian cancer.
G. Kristensen
Consultant or Advisory Role - Roche
T. Perren
No relevant relationships to disclose
W. Qian
No relevant relationships to disclose
J. Pfisterer
No relevant relationships to disclose
J. A. Ledermann
No relevant relationships to disclose
F. Joly
No relevant relationships to disclose
M. S. Carey
No relevant relationships to disclose
P. J. Beale
No relevant relationships to disclose
A. Cervantes
No relevant relationships to disclose
A. M. Oza
No relevant relationships to disclose